Company / SG&A Expense
DBV Technologies S.A. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$32.8M
FY2025
5-year range
$24.3M / $32.8M
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
#180 of 211
Health Care
What the data says
DBV Technologies S.A.'s sg&a expense of $33M is lower than 85% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 7 years, ranging from $24M in FY2022 to $49M in FY2019.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of -1.3%.
Increased from $30M to $33M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +10.5%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 211This company $32.8M Sector average $728.7M
▼
-95.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.3%, indicating a declining trend.
- In FY2025, sg&a expense increased 14.1% year-over-year.
- Ranks #180 out of 211 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.8M | +14.1% |
| FY2024 | $28.7M | -2.6% |
| FY2023 | $29.5M | +21.3% |
| FY2022 | $24.3M | -20.3% |
| FY2021 | $30.5M | -13.0% |
| FY2020 | $35.1M | -28.5% |
| FY2019 | $49.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026